These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30205879)

  • 1. CRISPR/Cas9 genome engineering in hematopoietic cells.
    Sürün D; von Melchner H; Schnütgen F
    Drug Discov Today Technol; 2018 Aug; 28():33-39. PubMed ID: 30205879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
    Wang L; Zheng W; Liu S; Li B; Jiang X
    Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 as a Tool in Cancer Therapy.
    Zatloukalová P; Krejčíř R; Valík D; Vojtěšek B
    Klin Onkol; 2019; 32(Supplementum 3):13-18. PubMed ID: 31627701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CRISPR/Cas9 System and Its Advances in Gene Therapy of Hematologic Diseases--Review].
    Li WY; Gao QP; Liu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1863-1867. PubMed ID: 30501735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of CRISPR-Cas system in gene therapy: Pre-clinical progress in animal model.
    Guan L; Han Y; Zhu S; Lin J
    DNA Repair (Amst); 2016 Oct; 46():1-8. PubMed ID: 27519625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR to fix bad blood: a new tool in basic and clinical hematology.
    González-Romero E; Martínez-Valiente C; García-Ruiz C; Vázquez-Manrique RP; Cervera J; Sanjuan-Pla A
    Haematologica; 2019 May; 104(5):881-893. PubMed ID: 30923099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.
    Uppada V; Gokara M; Rasineni GK
    Gene; 2018 May; 656():22-29. PubMed ID: 29496558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection.
    Deng Q; Chen Z; Shi L; Lin H
    Rev Med Virol; 2018 Sep; 28(5):e1998. PubMed ID: 30024073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of CRISPR/Cas9 system in gene therapy.
    Mollanoori H; Teimourian S
    Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.
    Humbert O; Samuelson C; Kiem HP
    Br J Haematol; 2021 Jan; 192(1):33-49. PubMed ID: 32506752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
    Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome editing for human gene therapy.
    Meissner TB; Mandal PK; Ferreira LM; Rossi DJ; Cowan CA
    Methods Enzymol; 2014; 546():273-95. PubMed ID: 25398345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.
    Yi L; Li J
    Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.